Szekely-Kohn A, Castellani M, M Espino D, Baronti L, Ahmed Z, Manifold W
R Soc Open Sci. 2025; 12(1):241052.
PMID: 39845718
PMC: 11750376.
DOI: 10.1098/rsos.241052.
Pahlevan Kakhki M, Giordano A, Cucuzza C, Venkata S Badam T, Samudyata S, Lemee M
Nat Commun. 2024; 15(1):6419.
PMID: 39079955
PMC: 11289459.
DOI: 10.1038/s41467-024-50794-z.
Swanberg K, Landheer K, Pitt D, Juchem C
Front Neurol. 2019; 10:1173.
PMID: 31803127
PMC: 6876616.
DOI: 10.3389/fneur.2019.01173.
Singhal N, Alkhayer K, Shelestak J, Clements R, Freeman E, McDonough J
Mol Neurobiol. 2018; 55(10):8051-8058.
PMID: 29498007
DOI: 10.1007/s12035-018-0971-6.
Wood E, Ercan E, Sati P, Cortese I, Ronen I, Reich D
Neuroimage Clin. 2017; 15:780-788.
PMID: 28702353
PMC: 5496488.
DOI: 10.1016/j.nicl.2017.06.028.
Assessing Repair in Multiple Sclerosis: Outcomes for Phase II Clinical Trials.
Sormani M, Pardini M
Neurotherapeutics. 2017; 14(4):924-933.
PMID: 28695472
PMC: 5722763.
DOI: 10.1007/s13311-017-0558-3.
The neuronal metabolite NAA regulates histone H3 methylation in oligodendrocytes and myelin lipid composition.
Singhal N, Huang H, Li S, Clements R, Gadd J, Daniels A
Exp Brain Res. 2016; 235(1):279-292.
PMID: 27709268
PMC: 5875422.
DOI: 10.1007/s00221-016-4789-z.
Neuronal Hemoglobin Expression and Its Relevance to Multiple Sclerosis Neuropathology.
Brown N, Alkhayer K, Clements R, Singhal N, Gregory R, Azzam S
J Mol Neurosci. 2016; 59(1):1-17.
PMID: 26809286
PMC: 4851882.
DOI: 10.1007/s12031-015-0711-6.
Changes in Methionine Metabolism and Histone H3 Trimethylation Are Linked to Mitochondrial Defects in Multiple Sclerosis.
Singhal N, Li S, Arning E, Alkhayer K, Clements R, Sarcyk Z
J Neurosci. 2015; 35(45):15170-86.
PMID: 26558787
PMC: 6605362.
DOI: 10.1523/JNEUROSCI.4349-14.2015.
Systematic imaging review: Multiple Sclerosis.
Katdare A, Ursekar M
Ann Indian Acad Neurol. 2015; 18(Suppl 1):S24-9.
PMID: 26538845
PMC: 4604694.
DOI: 10.4103/0972-2327.164821.
Decreased NAA in gray matter is correlated with decreased availability of acetate in white matter in postmortem multiple sclerosis cortex.
Li S, Clements R, Sulak M, Gregory R, Freeman E, McDonough J
Neurochem Res. 2013; 38(11):2385-96.
PMID: 24078261
PMC: 3880684.
DOI: 10.1007/s11064-013-1151-8.
Two-year serial whole-brain N-acetyl-L-aspartate in patients with relapsing-remitting multiple sclerosis.
Rigotti D, Inglese M, Kirov I, Gorynski E, Perry N, Babb J
Neurology. 2012; 78(18):1383-9.
PMID: 22517095
PMC: 3345790.
DOI: 10.1212/WNL.0b013e318253d609.
New imaging techniques in the diagnosis of multiple sclerosis.
Fu Y, Talavage T, Cheng J
Expert Opin Med Diagn. 2009; 2(9):1055-65.
PMID: 19337386
PMC: 2662586.
DOI: 10.1517/17530050802361161.
Proton magnetic resonance spectroscopy in multiple sclerosis.
Sajja B, Wolinsky J, Narayana P
Neuroimaging Clin N Am. 2008; 19(1):45-58.
PMID: 19064199
PMC: 2615006.
DOI: 10.1016/j.nic.2008.08.002.
Pharmacological treatment of early multiple sclerosis.
Stuve O, Bennett J, Hemmer B, Wiendl H, Racke M, Bar-Or A
Drugs. 2007; 68(1):73-83.
PMID: 18081373
DOI: 10.2165/00003495-200868010-00005.
Whole-brain N-acetylaspartate as a surrogate marker of neuronal damage in diffuse neurologic disorders.
Rigotti D, Inglese M, Gonen O
AJNR Am J Neuroradiol. 2007; 28(10):1843-9.
PMID: 17921226
PMC: 8134227.
DOI: 10.3174/ajnr.A0774.
Multiple sclerosis: the role of MR imaging.
Ge Y
AJNR Am J Neuroradiol. 2006; 27(6):1165-76.
PMID: 16775258
PMC: 8133908.
Magnetic resonance spectroscopy in the monitoring of multiple sclerosis.
Narayana P
J Neuroimaging. 2005; 15(4 Suppl):46S-57S.
PMID: 16385018
PMC: 1351238.
DOI: 10.1177/1051228405284200.